e-learning
resources
Vienna 2012
Monday, 03.09.2012
Translational respiratory medicine in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effectiveness of tiotropium in low-risk patients according to new GOLD severity grading
D. Halpin, M. Decramer, B. Celli, A. Martín, I. Leimer, N. Metzdorf, D. Tashkin (Exeter, United Kingdom; Leuven, Belgium; Boston, New York, Los Angeles, United States Of America; Ingelheim, Germany)
Source:
Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Session:
Translational respiratory medicine in asthma and COPD
Session type:
Thematic Poster Session
Number:
2190
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Halpin, M. Decramer, B. Celli, A. Martín, I. Leimer, N. Metzdorf, D. Tashkin (Exeter, United Kingdom; Leuven, Belgium; Boston, New York, Los Angeles, United States Of America; Ingelheim, Germany). Effectiveness of tiotropium in low-risk patients according to new GOLD severity grading. Eur Respir J 2012; 40: Suppl. 56, 2190
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Health status in the GOLD guidelines era. Assessing the new COPD severity staging criteria
Source: Eur Respir J 2002; 20: Suppl. 38, 251s
Year: 2002
GOLD assessment of COPD patients: Impact of symptoms assessment choice
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Combined COPD assessment using the new GOLD guidelines
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Impact of comorbidities on survival of patients with COPD according to GOLD stages
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011
Relationship between quality of life and severity of COPD according to GOLD classification
Source: Eur Respir J 2004; 24: Suppl. 48, 15s
Year: 2004
The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Adherence to pharmacotherapy of Colombian patients with COPD according to GOLD 2019
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020
Evaluation of prevalence of COPD according to different criteria
Source: Eur Respir J 2002; 20: Suppl. 38, 124s
Year: 2002
10-year cumulative incidence of COPD in a symptomatic cohort using BTS and GOLD spirometric criteria
Source: Eur Respir J 2003; 22: Suppl. 45, 214s
Year: 2003
The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Psychologic impairment according to GOLD COPD staging for patients in a primary care setting
Source: Annual Congress 2007 - Managing COPD in primary care
Year: 2007
Distribution of COPD patients in the GOLD assessment framework by exacerbations
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Use of GOLD staging as a guide for treating COPD patients in primary care
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011
An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004
Validation of non-spirometric predictors of COPD to the GOLD stage classification
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept